English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduSix Mayo Clinic staff are award recipients in Cohort II of the Robert A. Winn Diversity in Clinical Trials Career Development Award. The two-year program aims to train, develop and mentor diverse and community-oriented researchers and physicians to help increase the diversity of patients enrolled in clinical trials, and ultimately to enhance the development of therapeutics for all populations.
Tag: Diversity in clinical trials
Cedars-Sinai Cancer Experts Available to Comment on AACR Cancer Disparities Progress Report
Experts from Cedars-Sinai Cancer are available to comment on the American Association for Cancer Research (AACR) Cancer Disparities Progress Report 2022, which will be released Wednesday, June 8, in a virtual congressional briefing. The report highlights the need to increase diversity in clinical trials and the cancer workforce, and it provides policy recommendations for addressing cancer disparities—all areas Cedars-Sinai Cancer is working to address.
New national faith-based community engagement initiative to partner with key communities around COVID-19 and CoVPN clinical trials
With many communities across the U.S. disproportionately impacted by the COVID-19 pandemic, the recently formed COVID-19 Prevention Network (CoVPN), has established a national, faith-based program called the CoVPN Faith Initiative to enhance trust and meaningful engagement in key communities and provide accurate and updated information about COVID-19 and CoVPN clinical trials.
Clinical trials for potential COVID-19 vaccines need to include a more diverse roster of participants
Those who lead clinical trials for potential COVID-19 vaccines need to include more minorities. According to Marjorie A. Speers, executive director of non-profit Clinical Research Pathways and a former CDC official, Black and Latino patients are vastly under-represented in most…
Epidemiology expert: Strive for diversity in COVID-19 vaccine/drug clinical trials
As clinical trials on potential vaccines and treatment drugs for the COVID-19 disease caused by the novel coronavirus get underway, researchers should strive for diversity in test subject selection, according to a leading expert on the topic. Marjorie A. Speers,…
Expert in #expandedaccess to experimental drugs and diversity in clinical trials to speak at D.C. conf., and is available for interviews
An international expert in expanded access to experimental drugs, Marjorie A. Speers, Ph.D., will speak at the third annual Expanded Access Summit Jan. 27-29 at the National Press Club in Washington, D.C. Speers, a former CDC official, is the executive…